|Wednesday||1:30 PM - 3:30 PM||lesson||Lecture Hall B|
|Friday||11:30 AM - 1:30 PM||lesson||Lecture Hall H|
The aim of clinical proteomics is actually to find molecular signatures, to describe affected pathways and possibly identify candidate biomarkers that can help in the diagnosis, prognosis and prediction of therapeutic outcomes and elucidate pathogenic mechanisms.
Clinical proteomics course aims to give an overview of proteomics methodologies and their application to current areas of clinical investigation.
Introduction to clinical proteomics.
Strategies for protein sample preparation.
Gel-based and gel-free clinical proteomics analyses.
Protein Identification by Tandem Mass Spectrometry.
Label-Based MS clinical proteomic approaches.
Advances in clinical proteomics research for biomarkers discovery.
Clinical Proteomics for elucidating the mechanism of action of anticancer drugs.
Clinical Proteomics to study Pancreatic Cancer Stem Cells
Hepcidin assay and clinical application
Recent Advances in Cardiovascular disease
The final exam includes the presentation of a scientific paper and a written exam that will cover all the topics of the program.
Cà Vignal 1, Strada Le Grazie 15, 37134 Verona
VAT number 01541040232
Italian Fiscal Code 93009870234
© 2020 | Verona University | Credits